Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
Comparison of the NOACs -Pharmacokinetics. | Download Table
Frontiers | Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach
Novel Oral Anticoagulants (NOACs) Roundtable: Hot Topics and Current Issues in association with Arrhythmia & Electrophysiology Review | AER Journal
Interpreting Safety Results of NOACs Based on Bleeding Risk | Thrombosis Adviser
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
Direct Oral Anticoagulants for Secondary Stroke Prevention - Practical Neurology
Direct Oral Anticoagulants in Patients With Active Cancer: A Systematic Review and Meta-Analysis - ScienceDirect
Comparison of Stroke and Bleeding Events | Download Table
Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study - Thrombosis Research
Comparison of upper gastrointestinal bleeding risk in users of warfarin... | Download Scientific Diagram
Safety of new oral anticoagulant drugs: a perspective - Juan Antonio Vílchez, Pilar Gallego, Gregory Y.H. Lip, 2014
Table 3 from Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management | Semantic Scholar
NOAC FAQs – Mitigation and management of the bleeding risk #2
Risk of Major Bleeding and Nonpersistence Following Full NOAC... | Download Table
Advantages and Disadvantages of Novel Oral Anticoagulants (NOACs) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban | Journal of the American Heart Association
Anticoagulation highlights from the ESC - The British Journal of Cardiology
![PDF] Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d172e163a9fa76c89dc1493ee7466fe717320b45/2-Table1-1.png "PDF] Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes | Semantic Scholar")
PDF] Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes | Semantic Scholar
NOAC FAQs – Mitigation and management of the bleeding risk #2
Schemes of discontinuation of NOACs. | Download Table
Comparison of NOACs in risk of major bleeding in patients with AF. AF =... | Download Scientific Diagram
![PDF] Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f6650714338788ce610c0f562e51869ceb57aaf9/1-Table1-1.png "PDF] Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. | Semantic Scholar")
PDF] Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. | Semantic Scholar
